Peptide Research Data

Anonymized, HIPAA de-identified peptide therapy outcomes data for pharmaceutical companies, research institutions, and insurance providers.

Anonymized, aggregated data on protocol adherence, symptom outcomes, and biomarker changes across peptide compounds.

N=10,000+ protocol months · 15+ compounds · 25+ biomarkers

Pharmaceutical R&DClinical trial designOutcomes research

Quarterly reports on peptide therapy outcomes including dose-response curves, side effect profiles, and population-level trends.

Quarterly delivery · IRB-ready · HIPAA de-identified

Regulatory submissionsInsurance outcomes dataMedical literature

Programmatic access to our protocol intelligence engine for integration into clinical decision support systems.

REST API · <200ms latency · 99.9% uptime SLA

EHR integrationClinical decision supportTelehealth platforms

Data Governance & Compliance

All data is HIPAA de-identified per Safe Harbor method (18 identifiers removed)

IRB-approved data governance framework

SOC 2 Type II compliant infrastructure

Patient consent obtained for aggregated research use

No individual patient data is ever shared or sold

Data access audited and logged per ISO 27001

Partnership Inquiry